✦ LIBER ✦

A phase I study of a novel lipopolymer-based interleukin-12 gene therapeutic in combination with chemotherapy for the treatment of platinum-sensitive recurrent ovarian cancer

✍ Scribed by R. Alvarez; K. Anwar; M. Barnes; J. Fewell

Book ID: 113962801
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 55 KB
Volume: 120
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2010.12.078

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of a formulated IL-12 plas

Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer

✍ Anwer, Khursheed; Kelly, F. Joseph; Chu, Christina; Fewell, Jason G.; Lewis, Dan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Corrigendum to: “Phase I trial of a form

Corrigendum to: “Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer” [Gynecol Oncol 131 (2013) 169–173]

✍ Anwer, Khursheed; Kelly, F. Joseph; Chu, Christina; Fewell, Jason G.; Lewis, Dan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A randomized phase II study evaluating t

A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer

✍ Kaye, S. B.; Poole, C. J.; Danska-Bidzinska, A.; Gianni, L.; Del Conte, G.; Gorb 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 251 KB

Phase II study of belotecan, a camptothe

Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer

✍ Chel Hun Choi; Yoo-Young Lee; Tae-Jong Song; Hwang-Shin Park; Min Kyu Kim; Tae-J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 2 views

Topotecan and carboplatin in patients wi

Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study

✍ Dominique Koensgen; Dirk Stengel; Antje Belau; Peter Klare; Guelten Oskay-Oezcel 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 324 KB

A phase II trial of intraperitoneal EGEN

A phase II trial of intraperitoneal EGEN-001, an interleukin (IL)-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: A GOG study

✍ Alvarez, R.D.; Sill, M.; Davidson, S.A.; Muller, C.; Bender, D.P.; DeBernardo, R 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 94 KB